In recent trading, shares of Treace Medical Concepts Inc (TMCI) have crossed above the average analyst 12-month target price of $7.50, changing hands for $7.76/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..